Vijay Srinivasan, MBBS, MD, works in research and quality improvement programs dealing with critical illness endocrinopathies and nutrition to improve outcomes in critically ill children. His research focuses on stress hyperglycemia with tight glycemic control and nutrition therapy.
Dr. Hill’s research interests include identifying strategies to help parents, children, and healthcare providers cope with stressful situations; coping skills in the context of serious illness; how parents develop new goals when a child’s health is declining; good parent beliefs of parents of seriously ill children; and changes in self-concept for parents caring for a child with a life-threatening illness.
Dr. Argon investigates the unfolded protein response (UPR) , an essential signaling network that determines life or death of stressed cells and tissues. The IRE1 sensor of UPR responds to metabolic stress through four distinct activities and he focuses on determining which stress condition induces each activity and how they are integrated to enable the cells to cope with stress.
Dr. Kassam-Adams’ current research focuses on data sharing and data harmonization in traumatic stress research, and on the development and evaluation of tools that enable trauma-informed and family-centered care in pediatric health settings. Current National Institutes of Health-funded projects include an eHealth tool incorporating game-based screening of child symptoms and functioning, and online training for providers in non-pediatric emergency departments.
Dr. Cole is a pediatric neuro-oncologist who has dedicated her career to translational and clinical research, combining her expertise in molecular pathology, cancer genomics, and developmental therapeutics to identify novel treatments for children with cancer.
Dr. Bhatnagar's research aims to further the understanding of the neural basis of individual differences in response to stressful experiences. This includes identifying neural substrates that produce resiliency or vulnerability to the effects of stress and determining treatments to mitigate vulnerability and to promote resiliency through both preclinical and translational studies.
Dr. Eisch is a neuroscientist interested in how molecular, cellular, and circuit changes—particularly in the limbic system—influence motivated behavior and cognition. She is specifically interested in how neuroplasticity in the hippocampal dentate gyrus contributes to both normal and pathological function with relevance to depression and addiction.
Dr. Tong investigates cytokine receptor signaling in normal and neoplastic hematopoietic development. She uses integrated approaches encompassing biochemistry, molecular biology, mouse models, and primary human samples to understand signaling events emanating from cytokine receptors that regulate the development of hematopoietic stem/progenitor cells.